Multiple Assemblies exist for SMTL entry 9ncv
Crystal Structure of WDR5 in complex with Triazole-Based Inhibitors; X-RAY DIFFRACTION 1.58 Å

	SMTL ID 9ncv.1 Ligands (6P)-6-[1-ethyl-3-(trifluoromethyl)-1H-pyrazol-4-yl]-3-[(4-fluoro-3-methylphenyl)methyl]-8-[(2-methyl-1H-imidazol-1-yl)methyl]-4,5-dihydro-3H-naphtho[1,2-d][1,2,3]triazole Polypeptides WD repeat-containing protein 5 Oligo-state monomer
	SMTL ID 9ncv.2 Ligands (6P)-6-[1-ethyl-3-(trifluoromethyl)-1H-pyrazol-4-yl]-3-[(4-fluoro-3-methylphenyl)methyl]-8-[(2-methyl-1H-imidazol-1-yl)methyl]-4,5-dihydro-3H-naphtho[1,2-d][1,2,3]triazole Polypeptides WD repeat-containing protein 5 Oligo-state monomer
	SMTL ID 9ncv.3 Ligands (6P)-6-[1-ethyl-3-(trifluoromethyl)-1H-pyrazol-4-yl]-3-[(4-fluoro-3-methylphenyl)methyl]-8-[(2-methyl-1H-imidazol-1-yl)methyl]-4,5-dihydro-3H-naphtho[1,2-d][1,2,3]triazole Polypeptides WD repeat-containing protein 5 Oligo-state monomer
	SMTL ID 9ncv.4 Ligands (6P)-6-[1-ethyl-3-(trifluoromethyl)-1H-pyrazol-4-yl]-3-[(4-fluoro-3-methylphenyl)methyl]-8-[(2-methyl-1H-imidazol-1-yl)methyl]-4,5-dihydro-3H-naphtho[1,2-d][1,2,3]triazole Polypeptides WD repeat-containing protein 5 Oligo-state monomer